Table 3.
CD44, MMP-2, and MMP-9 immunoreactivity of papillary renal cell carcinoma.
Overall Immunohistochemical Score | CD44 | MMP-2 | MMP-9 |
---|---|---|---|
Group 1 (low expression) (n (%)) | 28 (68.29%) | 27 (65.85%) | 31 (75.61%) |
Group 2 (moderate expression) (n (%)) | 8 (19.51%) | 11 (26.83%) | 6 (14.63%) |
Group 3 (high expression) (n (%)) | 5 (12.20%) | 3 (7.32%) | 4 (9.76%) |